Journal article
Desmopressin for diabetes insipidus, hemostatic disorders and enuresis
American family physician, v 42(4), pp 1051-1057
01 Oct 1990
PMID: 2220513
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Arginine vasopressin preparations have been used in the treatment of diabetes insipidus for many years. Compared with older antidiuretic agents, the synthetic analog desmopressin is more potent, longer acting and easier to use. It is available for intravenous, subcutaneous and intranasal administration. Desmopressin may be useful in the treatment of hemostatic disorders such as von Willebrand's disease and hemophilia A. It has also been used for nocturnal enuresis. The vasopressor effects of arginine vasopressin preparations have been exploited for use as a temporizing measure in controlling acute gastrointestinal bleeding. Side effects such as hyponatremia and water intoxication are uncommon when these drugs are used with proper precautions.
Metrics
11 Record Views
Details
- Title
- Desmopressin for diabetes insipidus, hemostatic disorders and enuresis
- Creators
- L H ShulmanJ L MillerL I Rose
- Publication Details
- American family physician, v 42(4), pp 1051-1057
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Management
- Web of Science ID
- WOS:A1990EB62500014
- Scopus ID
- 2-s2.0-0025076939
- Other Identifier
- 991019184089604721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Primary Health Care